FindTrial
Sign In

Role of Hiraoka's Transurethral Detachment of Prostate and Biopsy of the Peripheral Zone in the Same Session after Repeated Negative Biopsies in the Diagnosis of Prostate Cancer

Role of Hiraoka's Transurethral Detachment of Prostate and Biopsy of the Peripheral Zone in the Same Session after Repeated Negative Biopsies in the Diagnosis of Prostate Cancer

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800019188
Enrollment
Unknown
Registered
2018-10-30
Start date
2018-10-28
Completion date
Unknown
Last updated
2018-11-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

prostate cancer

Interventions

Case series:TUDP

Sponsors

Department of Urology, ShengJing Hospital of China Medical University
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
60 Years to 80 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria were: patients with elevated and/or rising prostate specific antigen (PSA), normal digital rectum examination (DRE), normal tansrectal ultrasound (TRUS), and normal multiple parameter magnetic resonance image (mpMRI), negative prostate biopsies (at least 2 times systemic biopsy); moderate and severe LUTS caused by BOO (bladder outlet obstruction) and impaired quality of life (QoL score more than 3); prostate volume between 30ml and 100ml.

Exclusion criteria

Exclusion criteria: Exclusion criteria were as follows: patients with previous history of prostate surgery or with neurogenic bladder.

Design outcomes

Primary

MeasureTime frame
biopsy pathology;—

Countries

China

Contacts

Public ContactSong Bai

Department of Urology, ShengJing Hospital of China Medical University

baisongcmu@163.com+86 18940255568

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026